{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:32:01Z","timestamp":1770820321807,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014255","name":"Fonds de dotation CSL Behring pour la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014255","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.thromres.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T06:02:28Z","timestamp":1370498548000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Management of cardiovascular disease in haemophilia"],"prefix":"10.1016","volume":"132","author":[{"given":"Guillaume","family":"Cayla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Emmanuel","family":"Morange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Chambost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Schved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.thromres.2013.05.007_bb0005","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1365-2516.2009.02020.x","article-title":"Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline","volume":"15","author":"Schutgens","year":"2009","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2013.05.007_bb0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2516.2010.02262.x","article-title":"Cardiovascular disease in haemophilia patients: a contemporary issue","volume":"16","author":"Mannucci","year":"2010","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.thromres.2013.05.007_bb0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14656566.2012.656591","article-title":"Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia","volume":"13","author":"Mannucci","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2013.05.007_bb0020","first-page":"S27","article-title":"The aging patient with hemophilia","volume":"87","author":"Konkle","year":"2012","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.thromres.2013.05.007_bb0025","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1160\/TH09-11-0766","article-title":"Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment","volume":"103","author":"Coppola","year":"2010","journal-title":"Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2013.05.007_bb0030","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.thromres.2010.10.004","article-title":"Clinical challenges within the aging hemophilia population","volume":"127","author":"Konkle","year":"2011","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.thromres.2013.05.007_bb0035","first-page":"179","article-title":"Mild haemophilia A fails to protect from coronary artery disease: the report of two cases","volume":"25","author":"Paolini","year":"1993","journal-title":"Haematologia"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0040","article-title":"Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients","volume":"109","author":"Fransen van de Putte","year":"2012","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2013.05.007_bb0045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MBC.0b013e328345f582","article-title":"Cardiovascular disease risk factors: prevalence and management in adult hemophilia patients","volume":"22","author":"Lim","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"10.1016\/j.thromres.2013.05.007_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2516.2010.02463.x","article-title":"Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)","volume":"17","author":"Sharathkumar","year":"2011","journal-title":"Haemophilia"},{"issue":"26","key":"10.1016\/j.thromres.2013.05.007_bb0055","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1182\/blood-2009-07-215665","article-title":"How I treat age-related morbidities in elderly persons with hemophilia","volume":"114","author":"Mannucci","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.thromres.2013.05.007_bb0060","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/2012.jama.11348","article-title":"Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction","volume":"308","author":"Puymirat","year":"2012","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.thromres.2013.05.007_bb0065","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.thromres.2013.05.007_bb0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2516.2003.00765.x","article-title":"Continuous infusion","volume":"9","author":"Schulman","year":"2003","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2013.05.007_bb0075","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2516.2008.01950.x","article-title":"Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations","volume":"15","author":"Hermans","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2004.05110.x","article-title":"Dose and response in haemophilia\u2013optimization of factor replacement therapy","volume":"127","author":"Srivastava","year":"2004","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2011.02.039","article-title":"Bleeding avoidance strategies. Consensus and controversy","volume":"58","author":"Dauerman","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.thromres.2013.05.007_bb0090","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"issue":"9775","key":"10.1016\/j.thromres.2013.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.thromres.2013.05.007_bb0100","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/j.jacc.2012.06.017","article-title":"Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome: The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study","volume":"60","author":"Romagnoli","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.thromres.2013.05.007_bb0105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000093642","article-title":"Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature","volume":"116","author":"Girolami","year":"2006","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1016\/j.thromres.2013.05.007_bb0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-012-0802-y","article-title":"Percutaneous coronary intervention in patients with haemophilia presenting with acute coronary syndrome: an interventional dilemma: case series, review of the literature, and tips for management","volume":"35","author":"Fefer","year":"2012","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0115","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/j.1365-2516.2010.02355.x","article-title":"Percutaneous coronary intervention in a patient with acute non-ST-elevation myocardial infarction and haemophilia A: a 'genous' experience","volume":"17","author":"Petrillo","year":"2011","journal-title":"Haemophilia"},{"issue":"20","key":"10.1016\/j.thromres.2013.05.007_bb0120","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.thromres.2013.05.007_bb0125","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.thromres.2013.05.007_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijcard.2012.04.160","article-title":"An evidence-based review of current anti-platelet options for STEMI patients","volume":"166","author":"Cayla","year":"2012","journal-title":"Int J Cardiol"},{"issue":"20","key":"10.1016\/j.thromres.2013.05.007_bb0135","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.thromres.2013.05.007_bb0140","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.thromres.2013.05.007_bb0145","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.thromres.2013.05.007_bb0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2516.2005.01103.x","article-title":"Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant","volume":"11","author":"Krolick","year":"2005","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.thromres.2013.05.007_bb0155","first-page":"330","article-title":"Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature","volume":"16","author":"Arora","year":"2004","journal-title":"J Invasive Cardiol"},{"issue":"3","key":"10.1016\/j.thromres.2013.05.007_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4244\/51","article-title":"Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?","volume":"5","author":"Cuisset","year":"2009","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2516.2008.01895.x","article-title":"Cardiac surgery in patients with haemophilia","volume":"15","author":"Tang","year":"2009","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0170","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2516.2008.01918.x","article-title":"Cardiac surgery in patients with haemophilia B: a case report and review of the literature","volume":"15","author":"Krakow","year":"2009","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.thromres.2013.05.007_bb0175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0003-4975(10)65926-7","article-title":"Cardiovascular surgery in patients with congenital plasma coagulopathies","volume":"46","author":"Vander Woude","year":"1988","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"10.1016\/j.thromres.2013.05.007_bb0180","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1590\/S1807-59322009000800019","article-title":"Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient","volume":"64","author":"Pesaro","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"issue":"21","key":"10.1016\/j.thromres.2013.05.007_bb0185","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.thromres.2013.05.007_bb0190","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.thromres.2013.05.007_bb0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjmed.2010.05.007","article-title":"Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation","volume":"124","author":"Lip","year":"2011","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.thromres.2013.05.007_bb0200","first-page":"1360","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2011","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.thromres.2013.05.007_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.thromres.2013.05.007_bb0210","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.thromres.2013.05.007_bb0215","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1111\/j.1755-5922.2010.00197.x","article-title":"Alternatives to warfarin\u2013the next generation of anticoagulants","volume":"29","author":"Kanagasabapathy","year":"2011","journal-title":"Cardiovasc Ther"},{"issue":"10","key":"10.1016\/j.thromres.2013.05.007_bb0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.thromres.2013.05.007_bb0225","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.thromres.2013.05.007_bb0230","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.thromres.2013.05.007_bb0235","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2796.2012.02541.x","article-title":"New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation","volume":"271","author":"Tripodi","year":"2012","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.007_bb0240","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pharmthera.2010.12.007","article-title":"The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism","volume":"130","author":"Mavrakanas","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.thromres.2013.05.007_bb0245","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cpcardiol.2012.06.001","article-title":"Left atrial appendage occlusion for stroke prevention","volume":"37","author":"Alli","year":"2012","journal-title":"Curr Probl Cardiol"},{"issue":"9689","key":"10.1016\/j.thromres.2013.05.007_bb0250","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.thromres.2013.05.007_bb0255","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","article-title":"Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort","volume":"41","author":"Lip","year":"2010","journal-title":"Stroke"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813001990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813001990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:36:42Z","timestamp":1758735402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0049384813001990"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.05.007","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of cardiovascular disease in haemophilia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}